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Identification of polysaccharide 
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isolates
Aida González-Díaz1,2, Fe Tubau1,2, Miguel Pinto3, Yanik sierra1, Meritxell Cubero1,2, 
Jordi Càmara  1,2, Josefina Ayats1,2, Paula Bajanca-Lavado4, Carmen Ardanuy1,2 & 
Sara Marti1,2
The human commensal Haemophilus parainfluenzae is emerging as an opportunistic multidrug-resistant 
pathogen. The objectives of this work were to characterise a new capsular operon of extensively 
drug-resistant (XDR) H. parainfluenzae clinical isolates and study their resistance mechanisms using 
whole-genome sequencing. All strains were resistant to: ß-lactams, via amino acid changes in PBP3 
(S385T, I442F, V511A, N526K and V562I); quinolones, by alterations in GyrA (S84F and D88Y) and 
ParC (S84F and S138T); chloramphenicol, through the presence of catS; macrolides, via the presence 
of mel and mef(E)-carrying MEGA element; and tetracycline, through the presence of tet(M) and/or 
tet(B). Phylogenetic analysis revealed high genomic diversity when compared to the H. parainfluenzae 
genomes available on the NCBI, the isolates from this study being closely related to the Swiss XDR AE-
2096513. A full capsular operon showing homology to that of H. influenzae was identified, in accordance 
with the observation of a capsular structure by TEM. This study describes for the first time a capsular 
operon in H. parainfluenzae, a major determinant of pathogenicity that may contribute to increased 
virulence in XDR clinical isolates. Moreover, phylogenetic analysis suggests the possible spread of an 
XDR-encapsulated strain in Europe.
The members of the genus Haemophilus are pleomorphic and fastidious Gram-negative coccobacilli that require 
supplementary factors for in vitro growth, particularly V-factor (β-nicotinamide adenine dinucleotide, NAD) and/
or X-factor (haem)1,2. These nutritional requirements are essential in dividing this genus into three groups: the 
haem-dependent H. influenzae group (H. influenzae, H. haemolyticus and H. aegyptius); the haem-independent 
H. parainfluenzae group (H. parainfluenzae, H. parahaemolyticus, H. paraphrohaemolyticus, H. pittmaniae and 
H. sputorum); and the group containing H. ducreyi that requires haem, but not NAD for growth1. As a represent-
ative of the haem-independent group, H. parainfluenzae is characterised by its ability to synthesise haem, while 
depending on the presence of NAD in the environment for growth1.
H. parainfluenzae is part of the human oropharyngeal and genitourinary microbiota and is increasingly rec-
ognised as an opportunistic pathogen causing invasive, chronic or recurrent diseases, including respiratory tract 
infections3, meningitis4, endocarditis and pericarditis5, bone and joint infections6, and arthritis7. Recent reports 
have also linked this pathogen to genitourinary and sexually transmitted infections8–10, with one study observing 
unexpectedly high genital carriage in pregnant women that was frequently associated with antibiotic resistance 
traits8. In urethral exudates from men with acute Haemophilus spp. urethritis, H. parainfluenzae was observed 
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to be six times more frequent than H. influenzae10. Likewise, urinary tract infections in children have shown dif-
ferences with gender, with H. influenzae being the main species identified in girls and H. parainfluenzae in boys 
presenting urinary tract abnormalities, such as malformation, gross reflux or bladder dysfunction11. Moreover, 
H. parainfluenzae urethritis has also been described in men who have sex with men (MSM), highlighting the 
potential role of this microorganism in causing sexually transmitted diseases (STD)9.
Virulence factors play a crucial role in the invasion and infection process. Although the capsule has not yet 
been described in H. parainfluenzae, it is one of the most important virulence factors in H. influenzae and has 
been used for vaccine development. To date, six different capsular serotypes have been described for H. influenzae 
(a to f). The genes encoding the capsule are located in the cap locus, which is divided into three different regions. 
Region I contains four common genes (bexDCBA) that are responsible for the translocation of the capsular poly-
saccharides. Genes belonging to region II are serotype-specific and are associated with polysaccharide biosynthe-
sis. Finally, region III contains two genes (hcsAB) that are involved in post-polymerisation steps12.
Along with virulence factors, antimicrobial resistance is also important during the course of infection and 
identifying such resistance is required to apply correct antimicrobial treatment. H. parainfluenzae is often resist-
ant to β-lactam antibiotics13 and although resistance to fluoroquinolones and macrolides is still uncommon, 
isolates presenting reduced susceptibility to these antimicrobial agents are being increasingly reported14. In 2011, 
a multidrug-resistant (MDR) H. parainfluenzae clinical isolate, presenting resistance to quinolones, tetracy-
cline and co-trimoxazole, was reported in a patient with prostatitis in Spain15. Two years later in Switzerland, a 
case study of an MSM man co-infected with a pan-susceptible Neisseria gonorrhoeae isolate and an extensively 
drug-resistant (XDR) H. parainfluenzae strain was described16. XDR microorganisms are defined as resistant to 
at least one agent in all but two or fewer antimicrobial categories17 and are a significant cause for concern. Our 
study aimed to describe for the first time a capsule in four XDR H. parainfluenzae strains and fully characterise 
their molecular antibiotic resistance mechanisms.
Results
Characterisation of antimicrobial resistance. Three isolates were resistant to all the tested β-lactams 
(ampicillin, cefuroxime, cefotaxime, cefepime, amoxicillin/clavulanic acid and ceftriaxone), except for the car-
bapenems (imipenem and meropenem). A single isolate remained susceptible to amoxicillin/clavulanic acid and 
ceftriaxone. All the isolates were also resistant to chloramphenicol, macrolides, quinolones and co-trimoxazole, 
only remaining susceptible to rifampicin (Table 1).
The mechanisms of antimicrobial resistance were detected in silico (Table 1). Resistance to β-lactams was 
associated with amino acid substitutions in the penicillin-binding protein (PBP3). Five substitutions were pres-
ent in all the strains [S385T, I442F, V511A, N526K and V562I], while three additional changes [K276N, A307N 
and V329I] were only present in HUB12435, HUB12445 and HUB12640. The presence of β-lactamase was not 
detected in any of the isolates. Fluoroquinolone resistance was attributed to amino acid substitutions in DNA 
gyrase (GyrA) [S84F and D88Y] and in DNA topoisomerase IV subunit A (ParC) [S84F and S138T] and subunit 
B (ParE) [D420N and A451S]. Macrolide resistance was conferred by the amino acid substitution A69S in the 
50S ribosomal protein L4, encoded by the rplD gene, and by the acquisition of the MEGA element containing mel 
and mef(E). Tetracycline resistance was attributed to the tet(M) gene located upstream of the MEGA element, as 
described previously for H. parainfluenzae18. Resistance to chloramphenicol was linked to the presence of an acet-
yltransferase encoded by the catS (CP015430.1:976644-977267) gene. Moreover, the HUB11505 and HUB12640 
strains also acquired the tet(B) gene (NC_015964:1166619-1167824).
Phylogenetic diversity. Phylogenetic analysis involved the 35 H. parainfluenzae genomes that were availa-
ble on the NCBI database, including the H. parainfluenzae strain T3T1, which has a fully closed genome and was 
used as a reference strain for the phylogenetic analysis (Fig. 1). Overall, high intraspecies diversity was found, 
with an estimated core genome of around 42% and a total of 163,337 single nucleotide variants (SNVs). Despite 
this genetic diversity, the H. parainfluenzae strains isolated in this study were closely related (80% core genome 
and 30,955 SNVs) to an XDR strain from Switzerland (AE-2096513)16. Strains HUB12345 and HUB12445, iso-
lated from a single patient, were genetically indistinguishable
New capsular operon related to that of H. influenzae serotype c. A similar capsular operon was 
detected in all the strains, with a total length of 14,678 bp and 10 predicted ORFs. However, the capsular operon of 
HUB11505 presented a pcsB gene that was truncated at nucleotide position 5,613 by the insertion of an IS4 family 
transposase ISVsa5 previously identified in Haemophilus ducreyi (NZ_CP015434.1:125637-126845).
Figure 2 describes the genetic composition of the six H. influenzae and H. parainfluenzae capsular operons. A 
new name has been designated to each gene from the variable region II in H. parainfluenzae: pcsABCD. Regions I 
and III from serotypes c and d were not available on the NCBI database and hence, those genes were not included 
in the analysis. Supplementary Table 1 present the identity between each gene/protein from H. parainfluenzae 
and from the H. influenzae serotypes available on the NCBI database. Region I was the most conserved among 
the serotypes, with a high protein identity (>90%). Region III was also conserved, but the protein identity was 
lower than that of region I. The serotype-specific proteins from region II showed no identity with the new cap-
sular operon, except for the genes fcsA (serotype f), ccsA, ccsC and ccsD (serotype c). Although ccsD and pcsD 
presented high identity, ccsD from the NCBI database (HQ651151) had a 1-bp deletion at position 34 that resulted 
in a truncated protein.
Visualisation of capsular polysaccharides. Capsular polysaccharides were visually examined under 
the TEM, using H. influenzae serotype b and non-encapsulated H. parainfluenzae (bexA-negative) as controls. 
Cellular visualisation (Fig. 3) revealed that the non-encapsulated H. parainfluenzae was surrounded by a defined 
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bacterial cell membrane, which was significantly thinner than that of the encapsulated H. influenzae serotype b 
and the H. parainfluenzae strain HUB12445. Strain HUB11505, with a truncated pcsB gene, was also surrounded 
by a diffuse structure that could be classified as an intermediate between that of the encapsulated H. influenzae 
serotype b and the non-encapsulated H. parainfluenzae.
Discussion
H. parainfluenzae is a human commensal responsible for a large range of human infections, including genitou-
rinary infections. The putative role of this pathogen in STDs is a cause for concern. In this paper, we describe for 
first time the capsular operon of four XDR H. parainfluenzae clinical isolates from three patients with urogen-
ital infections, two males presenting urethritis and a female with vaginal discharge due to intra uterine device 
implantation.
The accumulation of many resistance mechanisms to several antimicrobial agents (ß-lactams, chlorampheni-
col, macrolides, quinolones, tetracycline and co-trimoxazole) leaves few available therapeutic options. Although 
β-lactam resistance is mainly due to the presence of β-lactamases19,20, the resistance in our strains was only associated 
with amino acid substitutions in the PBP3. These changes have been previously described in an H. parainfluenzae 
clinical isolate classified as a β-lactamase-negative ampicillin-resistant isolate (gBLNAR) from the III-like group13. 
Strain HUB11505 was susceptible to amoxicillin/clavulanic acid and ceftriaxone, possible due to the absence of 
substitutions K276N, A307N and V329I, which have already been reported16, but not conclusively proven to confer 
resistance to β-lactams. The analysis of the quinolone resistance-determining region (QRDR) of gyrA, parC and parE 
also revealed mutations that have been previously described21. The substitutions in DNA gyrase (S84F and D88Y) 
have been reported to be essential in the interaction between DNA and fluoroquinolones in H. influenzae22. Both 
substitutions, together with S84F in ParC, are the most common changes associated with fluoroquinolone resistance 
in Gram-negative bacteria. The ParC substitutions S84F and D420N, together with A451S in ParE have also been 
linked to high-level fluoroquinolone resistance in H. parainfluenzae, but their involvement in resistance has not 
been demonstrated15. The substitutions S138T and M198L have also been previously described8 outside the QRDR 
region in ParC, which might be involved with fluoroquinolone resistance14. Although the substitution A69S in the 
L4 protein has already been found in macrolide-resistant isolates23, a recent report also identified this mutation in 
susceptible strains, suggesting that it alone might not confer resistance to macrolides14. However, the decrease in 
susceptibility could also be explained by the presence of the macrolide efflux genetic assembly (MEGA) element, 
which is present in different bacteria and was found for the first time in an H. parainfluenzae isolate reported in 2013 
in Switzerland18. This element contains the mel and mef(E) genes, which encode a dual efflux pump that confers 
resistance to 14- and 15-membered lactone ring macrolides. Related to co-trimoxazole resistance, the I95L substitu-
tion in dihydrofolate reductase (DHFR) has been proposed to be involved in resistance24 and could be a homologue 
for the I100L substitution found in S. pneumoniae25. However, only two of the strains investigated in this study pre-
sented this change, suggesting that additional mechanisms might contribute to this resistance. Finally, all the strains 
Isolate Sex Age Source
ß-lactams Chloramphenicol
AMP AMC CXM CRO CTX FEP IPM MEM PBP3 CHL
HUB11505 M 25 Urethral 4 2/1 >8 ≤0,12 0,5 0.5 0,25 ≤0,25 S385T, I442F, V511A, N526K, V562I >8 catS
HUB12345a F 38 Vaginal >4 >4/2 >8 0,25 1 2 0,5 ≤0,25
K276N, A307N, V329I, 
S385T, I442F, V511A, 
N526K, V562I
>8 catS
HUB12445a F 38 Endocervical >4 >4/2 >8 0,25 1 2 0,5 ≤0,25
K276N, A307N, V329I, 
S385T, I442F, V511A, 
N526K, V562I
>8 catS
HUB 12640 M 35 Preputial 4 4/2 >8 0,25 1 2 0,5 ≤0,25
K276N, A307N, V329I, 
S385T, I442F, V511A, 
N526K, V562I
>8 catS
Isolate
Macrolides Quinolones Tetracycline Cotrimoxazole Rifampicin
ERY AZM L22 MEGA CIP LVX GyrA ParC ParE TET SXT DHFR RIF
HUB11505 >16 >4 A69S mef(E) >2 >4 S84F, D88Y S84F, S138T, M198L D420N, A451S >4 tet(M) tet(B) >2/38 1
HUB12345a >16 >4 A69S mef(E) >2 >4 S84F, D88Y S84F, S138T, M198L D420N, A451S >4 tet(M) >2/38 I95L 0.5
HUB12445a >16 >4 A69S mef(E) >2 >4 S84F, D88Y S84F, S138T, M198L D420N, A451S >4 tet(M) >2/38 I95L 0.5
HUB12640 >16 >4 A69S mef(E) >2 >4 S84F, D88Y S84F, S138T, M198L D420N, A451S >4 tet(M) tet(B) >2/38 0.5
Table 1. Strain data, MICs and molecular resistance mechanisms. MICs for each antibiotic are expressed 
in mg/L. Resistance based on the EUCAST criteria for H. influenzae is marked in bold. Resistance genotype 
refers to amino acid changes and acquired resistance mechanisms for ß-lactams, macrolides, quinolones, 
tetracycline and co-trimoxazole. AMP, ampicillin; AMC, amoxicillin/clavulanic acid; CXM, cefuroxime; CRO, 
ceftriaxone; CTX, cefotaxime; FEP, cefepime; IPM, imipenem; MEM, meropenem; CHL, chloramphenicol; 
ERY, erythromycin; AZM, azithromycin; CIP, ciprofloxacin; LVX, levofloxacin; TET, tetracycline; SXT, co-
trimoxazole; RIF, rifampicin. aIndicates isolates from the same patient obtained on the same day.
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presented catS, an acquired mechanism of resistance to chloramphenicol from H. ducreyi, suggesting the possible 
horizontal transfer of genetic material between strains from different species.
As observed in Fig. 1, H. parainfluenzae presents high intraspecies diversity with a low percentage of core 
genome and a high number of SNVs, in accordance with previous epidemiological studies performed by PFGE 
in our hospital (data not shown). The high genome plasticity in this species facilitates the exchange of genetic 
material with other microorganisms, enabling this species to act as a genetic reservoir of antimicrobial resistance. 
The strains isolated in this study shared a high percentage of core genome with the Swiss strain AE-2096513, 
HUB12435
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Figure 1. Phylogenetic relationship between the H. parainfluenzae strains. The 35 H. parainfluenzae genomes 
available on the NCBI database and the four XDR strains isolated in this study are presented in a core-single 
nucleotide variant (SNV) phylogenetic tree. Distance between the bacterial strains is represented in SNVs.
Figure 2. Genetic composition of H. influenzae and H. parainfluenzae capsular operons. Genes marked in dark 
grey belong to region I, while those from region III are marked in light grey. The sequences of H. influenzae 
serotypes c and d are not available on NCBI (genes represented by white dots in region I and genes represented 
by white stripes in region III). The ccsD gene represented by black dots has a 1-bp deletion, resulting in an 
interrupted gene. In the HUB11505 strain, pcsB is interrupted by a transposase, but there is an alternative ORF 
that has 471 fewer bp than that of HUB12435, HUB12445 and HUB12640. 1. ascD. 2. ecsF.
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also presenting very similar antimicrobial resistance profiles that differed mainly in co-trimoxazole resistance. 
Interestingly, AE-2096513 was most closely related to HUB11505 and HUB12640, suggesting the spread of this 
resistant clone in Europe possibly via sexual transmission. Further epidemiological studies are needed to verify 
the spread of these XDR H. parainfluenzae clones.
We identified and characterised a complete capsular operon for the first time in H. parainfluenzae. Since the capsule 
is one of the most important virulence factors in H. influenzae, this is a remarkable fact to consider in the surveillance 
of multidrug-resistant bacterial pathogens. Comparing the predicted genetic structure of the operons, the capsule 
identified in H. parainfluenzae presented the highest identity with that of H. influenzae serotype c, which is the least 
common serotype in this species. The high similarity between their capsules suggests that they might have a common 
ancestor. AE-2096513 was the only strain out of all those available in the NCBI database that presented a completely 
identical capsular operon to that of our clinical isolates, which was in accordance with the results of the phylogenetic 
analysis. Capsule visualisation by TEM indicated that the HUB12445 strain had a similar structure to that of encapsu-
lated H. influenzae b, in agreement with previous visualisations of the capsule by TEM26 and proving that the capsular 
operon was expressed in H. parainfluenzae. HUB11505, whose pcsB gene was interrupted by a transposase, also pre-
sented a capsule, but it was morphologically different to the capsule of HUB12445, suggesting that the alternative ORF 
shown in Fig. 2 encoded a functional protein that modified the polysaccharide composition of the capsule.
In conclusion, this study describes for the first time a capsular operon in H. parainfluenzae. The accumulation of 
resistance mechanisms leaves few therapeutic options in the treatment of these infections. Furthermore, phyloge-
netic analysis indicates a possible spread of this XDR clone in Europe that could be through sexual transmission.
Methods
Characterisation of the bacterial strains. Four XDR H. parainfluenzae strains were isolated from the 
urogenital exudates of three patients between January 2016 and January 2017: two males with urethritis and one 
female with pelvic inflammatory disease linked to an intrauterine device implantation (Table 1).
One of the male patients presented a positive PCR for Chlamydia trachomatis, but was negative for 
Neisseria gonorrhoeae. For the other male, no appropriate samples for PCR detection were collected, with only 
 H. parainfluenzae being detected by microbiological culture. The female patient had pelvic inflammatory disease, 
Figure 3. Capsule visualisation by TEM. (A,E) H. influenzae serotype b. (B,F) Non-encapsulated H. 
parainfluenzae. (C,G) Strain HUB12445. (D,H) Strain HUB11505. (1) Images acquired at a magnification of 
120,000x. (2) Images acquired at a magnification of 200,000x.
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with H. parainfluenzae isolated from both vaginal and endocervical exudates. PCR detection of C. trachomatis 
and N. gonorrhoeae gave negative results. Gardnerella vaginalis was also isolated from the endocervical exudate.
Clinical isolates were identified as H. parainfluenzae by MALDI-TOF mass spectrometry (Bruker Daltonik 
GmbH, Bremen, Germany). The strains used in this study were routinely grown in chocolate agar plates 
(bioMérieux, Marcy l’Etoile, France) or Haemophilus test medium (HTM) broth (Thermo Fisher Scientific, 
Massachusetts, USA) and incubated at 37 °C with 5%CO2. These strains produced smooth but non-mucoid grey-
ish colonies on chocolate agar plates.
The minimum inhibitory concentration (MIC) was determined by microdilution using commercial pan-
els (STRHAE2; Sensititre, Thermo Fisher Scientific) and interpreted following the guidelines of the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST)27. β-lactamase activity was tested using the chro-
mogenic cephalosporin method (nitrocefin disks, BD, New Jersey, USA).
Whole-genome sequencing and genome analysis. DNA was extracted using QIAamp DNA 
Blood Mini Kit (Qiagen, Hilden, Germany) and quantified using the QuantiFluor® dsDNA System (Promega, 
Wisconsin, USA). Nextera XT was used to prepare the libraries, followed by paired-end sequencing (2 × 150 bp) 
on an Illumina MiSeq Platform (Illumina Inc., San Diego, CA, USA), following the manufacturer’s instruc-
tions. The INNUca v2.6 pipeline (https://github.com/B-UMMI/INNUca) was used for read quality assess-
ment, improvement and genome assembly. Briefly, quality control of the reads was performed using FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and the reads were cleaned and improved 
with Trimmomatic28. The genome was assembled using SPAdes v3.1029 and subsequently polished. QA/QC 
statistics, genome depth of coverage and the number of contigs were monitored and reported throughout 
the analysis. All generated reads were deposited in the European Nucleotide Archive (accession numbers: 
HUB11505:ERS2616278, HUB12435:ERS2616279, HUB12445:ERS2616280 and HUB12640:ERS2616281).
An in silico screening of mutations targeting genes involved in antibiotic resistance was performed with 
Geneious R9 (Biomatters, Auckland, New Zealand), using the closed genome of the H. parainfluenzae strain T3T1 
(NC_015964) as reference. A screening of the acquired resistance genes was conducted using the Comprehensive 
Antibiotic Resistance Database (CARD)30, ARG-ANNOT31 and ResFinder 3.032.
Phylogenetic analysis was performed by constructing an assembly-based core-SNV phylogenetic tree includ-
ing the 35 H. parainfluenzae genomes available on the NCBI database and using the T3T1 strain as reference. 
Parsnp from the Harvest suite33 was used with default parameters, with the exception of parameter -C, which 
was adjusted to 5,000 to maximise the reference coverage. Phylogenetic tree visualisation was achieved with the 
graphic viewer FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
Capsular operon determination. The capsular operons of H. influenzae serotype a (CP017811:1472186-
1485236), serotype b (NC_016809:1190909-1206625), serotype c (HQ651151), serotype d (HM770877), sero-
type e (FM882247) and serotype f (CP005967:675016-687441) were used for a BLASTn search with Geneious 
R9 against our four assembled genomes and the open reading frames (ORF) were predicted. The percentage 
of identity between gene/proteins from H. parainfluenzae and that of the six capsular operons from H. influen-
zae was calculated as the identical number of bases/residues divided by the length of the longest gene/protein 
(Supplementary Table 1).
Since the capsular operon of the HUB11505 strain could not be resolved through whole-genome sequenc-
ing (WGS) data, we designed the primers 11505_F (5′-GGTTCTACCGACTCGTCTGC-3′) and 11505_R 
(5′-AGCATCTTCTTGTTTGATATATGCCG-3′) to close the gap by PCR amplification, followed by Sanger sequenc-
ing through primer walking, using primers 11505_F and 11505_F2 (5′-GTTCTCGCCTTTGGTTGGCAG-3′). 
The capsular operon of the H. parainfluenzae strain HUB12445 was deposited in the NCBI database with acces-
sion number MH644108.
Transmission electron microscopy for capsule visualisation. Four strains were selected to visualise the 
presence of the capsule: (a) H. influenzae strain HUB13399 serotype b as a positive control; (b) non-encapsulated 
H. parainfluenzae strain HUB13327 as a negative control; (c) H. parainfluenzae strains HUB12445 (full ccsB gene); 
and (d) H. parainfluenzae strain HUB11505 (ccsB gene interrupted by a transposase). Samples were fixed follow-
ing the lysine-acetate-based formaldehyde-glutaraldehyde ruthenium red-osmium fixation procedure (LRR fixa-
tion), as previously described34. Strains were grown overnight in HTM broth and centrifuged for 10 min at 1,800 g. 
Cells were then fixed, dehydrated, impregnated in resin and finally polymerised, as described for H. influenzae26. 
Ultra-thin sections were stained with 2% uranyl acetate, counterstained with lead citrate and visualised under JEOL 
1010 Transmission Electron Microscope (TEM) operated at 80 kV and equipped with a Orius camera (Gatan, Inc.).
Ethical statement. This study has been revised and approved for its publication by the Clinical Research Ethics 
Committee of the Hospital de Bellvitge (PR324/18). Written informed consent was not required as this is a retro-
spective and observational study with isolates obtained as part of the normal microbiological routine. Patient con-
fidentiality was always protected; all the data were anonymized and protected according to national normative.
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